Trial intelligence / Profile preview

Dose-ranging study of FLUVAL AB-like trivalent influenza vaccine in adults and elderly adults

2011-003166-32Phase 4Completed

Sponsor
Omninvest
Start
Jul 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of FluvalAB in influenza, sponsored by Omninvest. Started Jul 2011; status: completed.

02

Drugs

FluvalAB
03

Conditions

influenza

Beyond the preview

Go deeper on 2011-003166-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003166-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call